World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
147151
World Ranking
4099
National Ranking
2247

Overview

John M. Lachin is affiliated with George Washington University in the United States. Their research primarily focuses on Medicine, with significant contributions in Biochemistry, Genetics, and Molecular Biology. Within medicine, Lachin's work centers on Endocrinology, Diabetes, and Metabolism, complemented by studies in Genetics, Cardiology and Cardiovascular Medicine, Surgery, and Molecular Biology.

Their research output extensively covers topics related to diabetes and its management. Key thematic areas include:

  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Diabetes and Associated Disorders
  • Pancreatic Function and Diabetes
  • Metabolism, Diabetes, and Cancer
  • Cardiovascular Function and Risk Factors
  • Diabetes, Cardiovascular Risks, and Lipoproteins

Lachin has contributed to multiple high-impact publications, with recent notable papers as follows:

  • "Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study," 2020, Diabetes
  • "Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes," 2022, New England Journal of Medicine
  • "Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes," 2022, New England Journal of Medicine
  • "Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)," 2021, Diabetes Care
  • "Cognitive Performance Declines in Older Adults with Type 1 Diabetes: Results from 32 Years of Follow-up in the DCCT and EDIC Study," 2021, The Lancet Diabetes & Endocrinology

Frequent publication venues reflect the core of Lachin's research domains, with numerous papers published in:

  • Diabetes Care
  • Diabetes
  • UNC Libraries
  • New England Journal of Medicine
  • The Lancet Diabetes & Endocrinology

Lachin collaborates regularly with a set of coauthors, including:

  • Ionut Bebu
  • Barbara H. Braffett
  • Steven E. Kahn
  • Rose Gubitosi-Klug
  • Kieren J. Mather

Their scientific work intertwines clinical and molecular approaches across diabetes and related cardiovascular and genetic fields, bridging long-term metabolic studies with outcomes research. This is evidenced by involvement in major longitudinal trials such as the Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications (EDIC) Study, which explore glycemic control and its extended effects on diabetic complications and cognitive outcomes.

Best Publications

  • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

    Diabetes Control;D M Nathan;S Genuth

  • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

    W. C. Knowler;E. Barrett-connor;S. E. Fowler;R. F. Hamman

  • Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

    Bernard Zinman;Christoph Wanner;John M. Lachin;David Fitchett

  • Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

    David M. Nathan;Patricia A. Cleary;Jye Yu C Backlund;Saul M. Genuth

  • Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

    Kahn Se;Haffner Sm;Heise Ma;Herman Wh

  • Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

    Jennifer B Green;M. Angelyn Bethel;Paul W Armstrong;John B Buse

  • Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

    Diabetes Control;Complications Trial

  • Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes

    Richard F. Hamman;Rena R. Wing;Sharon L. Edelstein;John M. Lachin

  • Introduction to sample size determination and power analysis for clinical trials.

    John M. Lachin

  • Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

    David M Nathan;John Lachin;Patricia Cleary;Trevor Orchard

  • Effects of insulin in relatives of patients with type 1 diabetes mellitus

    J. S. Skyler;D. Brown;H. P. Chase;E. Collier

  • Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

  • Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

    David Fitchett;Bernard Zinman;Bernard Zinman;Christoph Wanner;John M. Lachin

  • Statistical considerations in the intent-to-treat principle.

    John M. Lachin

  • Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program

    William H. Herman;Yong Ma;Gabriel Uwaifo;Steven Haffner

  • Rosiglitazone-associated Fractures in Type 2 Diabetes: An Analysis From A Diabetes Outcome Progression Trial (ADOPT)

    Steven E. Kahn;Bernard Zinman;John M. Lachin;Steven M. Haffner

  • Achieving weight and activity goals among diabetes prevention program lifestyle participants.

    Rena R Wing;Richard F Hamman;George A Bray;Linda Delahanty

  • Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes

    Ian H. De Boer;Wanjie Sun;Patricia A. Cleary;John M. Lachin

  • How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

    Silvio E Inzucchi;Bernard Zinman;David Fitchett;Christoph Wanner

  • Rituximab, B-lymphocyte depletion, and preservation of beta-cell function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

Frequent Co-Authors

David M. Nathan
David M. Nathan Harvard University
Bernard Zinman
Bernard Zinman University of Toronto
William H. Herman
William H. Herman University of Michigan–Ann Arbor
Trevor J. Orchard
Trevor J. Orchard University of Pittsburgh
Michael W. Steffes
Michael W. Steffes University of Minnesota
Steven E. Kahn
Steven E. Kahn University of Washington
Rury R. Holman
Rury R. Holman University of Oxford
Mark E. Molitch
Mark E. Molitch Northwestern University
William F. Rosenberger
William F. Rosenberger George Mason University
Jerry P. Palmer
Jerry P. Palmer University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of Medicine in the USA opens doors to a wide range of online degrees and diverse healthcare career options. For those looking to become a nurse, you can fast-track your journey through absn programs that don't require teas, eliminating some of the most common entrance exam barriers.

If you’re interested in healthcare leadership, accelerated healthcare administration degree programs offer flexible options to quickly prepare for roles in hospital management and policy. Registered nurses aiming to become family nurse practitioners can consider seamless transition pathways with rn to fnp programs, empowering you to serve in more advanced clinical roles.

Additionally, for those passionate about preventive care and wellness, studying with a fully online format in online nutrition degree programs can help launch or advance a career in nutritional science or counseling. These online pathways make healthcare education more accessible and support various interests across the medical field.

Best Scientists Citing John M. Lachin

Trending Scientists

Recently Published Articles